Industry
Health Care & Social Assistance Pain Reliever
Keywords
biotechnology life sciences brown fat obesity metabolic disease diabetes biotech
Ember Therapeutics is a biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein-7 (BMP-7) and related family of BMPs, mutants, variants, novel formulations, and delivery technologies to develop regenerative medicines for disease modification of osteoarthritis, reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases such as chronic kidney disease and Alport Syndrome.
Ember Therapeutics is a biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein-7 (BMP-7) and related family of BMPs, mutants, variants, novel formulations, and delivery technologies to develop regenerative medicines for disease modification of osteoarthritis, reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases such as chronic kidney disease and Alport Syndrome.

Sponsor Details

People
If you currently work at this organization, click the “Do you work here?” button to request editing privileges.
This SponsorPitch page is about Ember Therapeutics and contains information about this organization's sponsorship activity, sponsorship decision makers and sponsorship preferences. This page is not endorsed by or affiliated with Ember Therapeutics, though it may be actively managed and updated by company representatives. If you currently work at this organization, click the Do you work here button to request management privileges. All trademarks, service marks and copyrights are property of their respective owners.